La Jolla Pharmaceutical Co.

La Jolla Pharmaceutical Co.

LJPC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$198.58M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
La Jolla Pharmaceutical Co.La Jolla Pharmaceutical Co.10.7--2%6.2-
$7.56

Current Fair Value

22.1% upside

Undervalued by 22.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$198.58 Million
Enterprise Value$153.32 Million
Earnings per Share$0.58
Beta2.41
Outstanding Shares32,081,000

Return

Return on Equity-2.19%ROE
Return on Assets1.53%
Return on Invested Capital16.86%

Valuation & Multiples

P/E Ratio10.67P/E Ratio
PEG-31.25PEG
Price to Sales6.19Price to Sales
Price to Book Ratio-2.06Price to Book Ratio
Enterprise Value to Revenue-0.97
Enterprise Value to EBIT-3.24
Enterprise Value to Net Income100
Total Debt to Enterprise-0.07
Debt to Equity-0.04Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About La Jolla Pharmaceutical Co.

La Jolla Pharmaceutical Insider Information FAQ

In the latest 13F quarter on Stockcircle, 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.